Community transmission of extended-spectrum β-lactamase [3]

Emerging Infectious Diseases

Volumn 9, Issue 8, 2003, Pages 1024-1025

  Mirelis, Beatriz ^a,b   Navarro, Ferran ^a,b   Miró, Elisenda ^a   Jesús Mesa, Raul ^a   Coll, Pere ^a,b   Prats, Guillem ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZTREONAM; BETA LACTAM; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; BIOASSAY; COMMUNICABLE DISEASE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FECES ANALYSIS; HUMAN; INFECTION RATE; KLEBSIELLA PNEUMONIAE; LETTER; NONHUMAN; PROTEUS MIRABILIS;

EID: 0041624472     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0908.030094     Document Type: Letter

References (11)

1. Briñas L, Zarazaga M, Saenz Y, Ruiz-Larrea F, Torres C. β-Lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals. Antimicrob Agents Chemother 2002;46:3156-63.
2. Österblad M, Hakanen A, Manninen R, Leistevuo T, Peltonen R, Meurman O, et al. A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora. Antimicrob Agents Chemother 2000;44:1479-84.
3. Murray P, Baron E, Pfaller M, Tenover F, Yolken R. Manual of clinical microbiology. 7th ed. Washington: American Society for Microbiology; 1999.
4. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test. Document M2-A7. 7th ed. Wayne (PA): The Committee; 2000.
5. National Committee for Clinical Laboratory Standards. Supplemental tables: disk diffusion. Document M100-S10. Wayne (PA): The Committee; 2000.
6. Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995;8:557-84.
7. Sabaté M, Miró E, Navarro F, Vergés C, Aliaga R, Mirelis B, et al. Beta-lactamases involved in resistance to broad-spectrum cephalosporins in Escherichia coli and Klebsiella spp. clinical isolates collected between 1994 and 1996, in Barcelona (Spain). J Antimicrob Chemother 2002;49:989-97.
8. Hernández JR, Pascual A, Cantón R, Martínez-Martínez L, Grupo de Estudio de Infección Hospitalaria (GEIH). Escherichia coli y Klebsiella pneumoniae productores de betalactamasas de espectro extendido en hospitales españoles (Proyecto GEIH-BLEE 2000). Enferm Infecc Microbiol Clin 2003;21:77-82.
9. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001;8:178-82.
10. Garau J, Xercavins M, Rodríguez-Carballeira M, Gómez-Vera JR, Coll I, Vidal D, et al. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother 1999;43:2736-41.
11. Tomasz A. New faces of an old pathogen: emergence and spread of multidrug-resistant Streptococcus pneumoniae. Am J Med 1999;107:55S-62S.